Shares of DaVita healthCare Partners Inc. (NYSE:DVA) Sees Large Outflow of Money - Money Flow Index Print

DaVita healthCare Partners Inc. (NYSE:DVA) surged 0.81% during the last session. The last traded price was up 0.65 points at $81.14. The data for the fund flow suggests that the net intraday money flow was $(-9.53) million. The fund value in upticks was recorded to be $22.34 million and in downticks, it was found to be $31.87 million. The up/down ratio for the day was measured to be 0.7. For the week, the shares have seen a percentage change of 2.67%.A block trade of $(-9.15) million in net money flow was also recorded during the day. For the block, the combined worth of upticks was $0 million and that of downticks was $9.15 million. The block tradeoff had the up/down ratio of 0.

DaVita Company has received recommendation from many analysts. Baird upgrades its rating on DaVita healthCare Partners Inc. (NYSE:DVA). The global brokerage major raises the current price target from $75 per share to $95 per share. Analysts at the Baird have a current rating of Outperform on the shares. The shares were previously rated Neutral. The rating by the firm was issued on April 27, 2015. DaVita healthCare Partners Inc. (NYSE:DVA) should head towards $90.2 per share according to 5 Analysts in consensus. However, if the road gets shaky, the stock may fall short to $85 per share. The higher price estimate target is at $96 according to the Analysts. The company shares have rallied 12.59% in the past 52 Weeks. On April 27, 2015 The shares registered one year high of $85.17 and one year low was seen on August 7, 2014 at $71.31. The 50-day moving average is $79.91 and the 200 day moving average is recorded at $79.85. S&P 500 has rallied 9.96% during the last 52-weeks. On a different note, The Company has disclosed insider buying and selling activities to the Securities Exchange, According to the information disclosed by the Securities and Exchange Commission in a Form 4 filing, the director officer (Co-Chairman of the Board) of Davita Healthcare Partners Inc., Margolis Robert J had sold 31,400 shares worth of $2,619,074 in a transaction dated June 3, 2015. In this transaction, 31,400 shares were sold at $83.41 per share. DaVita healthCare Partners Inc. (NYSE:DVA) rose 0.81% or 0.65 points on Thursday and made its way into the gainers of the day. After trading began at $80.49 the stock was seen hitting $81.29 as a peak level and $80.49 as the lowest level. The stock ended up at $81.14. The daily volume was measured at 1,514,103 shares. The 52-week high of the share price is $85.17 and the 52-week low is $71.1. The company has a market cap of $17,483 million. DaVita HealthCare Partners Inc., formerly DaVita Inc., is a provider of dialysis services in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease (ESRD). As of December 31, 2011, the Company provided dialysis and administrative services through a network of 1,809 outpatient dialysis centers located in the United States throughout 43 states and the District of Columbia, serving a total of approximately 142,000 patients. It also provides acute inpatient dialysis services in approximately 900 hospitals and related laboratory services throughout the United States. In July 2013, DaVita, a division of DaVita HealthCare Partners Inc announced the acquisition of the dialysis operations of Malaysias Caring Dialysis Centre Group (CDC Group) by DVA (Malaysia) Sdn Bhd.